Approval · Notice of Compliance 16355 · 2014
MANERIX: Notice of Compliance 16355
Issued November 25, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16355
- Date
- November 25, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Therapeutic class
- Antidepressant
Products in this notice
Medicinal ingredients
- MOCLOBEMIDE 150 MG per TAB
- MOCLOBEMIDE 300 MG per TAB